![Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07568-9/MediaObjects/12885_2020_7568_Fig1_HTML.png)
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr3.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffe8c2cb-a482-4e65-95db-70356dde0927/ejh12239-fig-0001-m.jpg)
Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Pilar-Garrido-2/publication/280998264/figure/fig3/AS:284610790477826@1444867908479/figure-fig3_Q320.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr1.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1f5b0bc0-32e9-4e7e-a668-784d55e0870f/ijcp_12022_f2.gif)
Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library
![Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe](http://www.oncoprescribe.com/app/uploads/_1406171985.jpg)
Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe
![Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering](https://pubs.acs.org/cms/10.1021/acsbiomaterials.9b00362/asset/images/large/ab-2019-00362z_0009.jpeg)
Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering
![Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.0c10764/asset/images/large/nn0c10764_0001.jpeg)
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
![Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram](https://www.researchgate.net/publication/324912322/figure/fig4/AS:865472643862537@1583356166698/Mechanism-of-action-of-abiraterone-acetate-enzalutamide-radium-223-dichloride_Q640.jpg)
Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram
![The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/193fffc9-ee92-40b4-bf45-765251811739/gr1.jpg)
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrew-Yee-7/publication/230850646/figure/fig1/AS:202882147196929@1425382281783/Mechanism-of-action-of-denosumab-compared-to-zoledronic-acid-Notes-RANKL-is-secreted-by_Q640.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr2.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/19/5/001.jpg)
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science
![Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article](https://assets.cureus.com/uploads/figure/file/90324/lightbox_56873fb01c7f11ea967fe109aa9b495a-Figure-2_formatted_V1-PME.png)
Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article
![Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo](https://www.spandidos-publications.com/article_images/mmr/17/4/MMR-17-04-5470-g06.jpg)
Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo
![Frontiers | Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis Frontiers | Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis](https://www.frontiersin.org/files/Articles/938447/fphar-13-938447-HTML/image_m/fphar-13-938447-g001.jpg)
Frontiers | Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis
![Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Semantic Scholar Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/366a9fa21911215bb089ce369250ff1587f47dbd/36-Figure9-1.png)